Guggenheim Initiates Coverage Of Opus Genetics (IRD) With “Buy” Rating And $16 Price TargetJune 11, 2026Yahoo Finance
Guggenheim Initiates Coverage Of Opus Genetics (IRD) With “Buy” Rating And $16 Price TargetJune 11, 2026Yahoo Finance
Guggenheim Initiates Coverage Of Opus Genetics (IRD) With “Buy” Rating And $16 Price TargetJune 11, 2026Yahoo Finance
Guggenheim Initiates Coverage Of Opus Genetics (IRD) With “Buy” Rating And $16 Price TargetJune 11, 2026Yahoo Finance
NRx Pharmaceuticals (NRXP) Closes Underwritten Public Offering of Common Stock At $3.50 Per ShareJune 11, 2026Yahoo Finance
NRx Pharmaceuticals (NRXP) Closes Underwritten Public Offering of Common Stock At $3.50 Per ShareJune 11, 2026Yahoo Finance
NRx Pharmaceuticals (NRXP) Closes Underwritten Public Offering of Common Stock At $3.50 Per ShareJune 11, 2026Yahoo Finance
NRx Pharmaceuticals (NRXP) Closes Underwritten Public Offering of Common Stock At $3.50 Per ShareJune 11, 2026Yahoo Finance
CFTC Proposes Sports Prediction Market Rules, Boosting DraftKings and Flutter SharesJune 11, 2026Yahoo Finance
